Skip to main content
. 2014 Aug 11;47(10):2941–2950. doi: 10.1021/ar5001617

Figure 3.

Figure 3

(a) CTC enumeration results obtained from 1st-gen NanoVelcro chips and a CellSearch assay on matched samples from 26 prostate cancer patients. (b) Serial CTC and PSA changes of a prostate cancer patient are plotted over his multiple treatment responses and progressions.